p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis
- 1 April 2003
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 3 (4), 387-402
- https://doi.org/10.1016/s1535-6108(03)00079-5
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Physical Interaction with Human Tumor-derived p53 Mutants Inhibits p63 ActivitiesJournal of Biological Chemistry, 2002
- ApoptosisCell, 2002
- Assessing TP53 status in human tumours to evaluate clinical outcomeNature Reviews Cancer, 2001
- Oncogenes Induce and Activate Endogenous p73 ProteinJournal of Biological Chemistry, 2001
- A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core DomainMolecular and Cellular Biology, 2001
- Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53Oncogene, 2001
- Mutant p53 protein expression interferes with p53-independent apoptotic pathwaysOncogene, 1998
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958